Detail
Article
Online article
FT
Medvik - BMC
  • Something wrong with this record ?

Genetic testing in the management of relatives of patients with hypertrophic cardiomyopathy

P. Tomašov, M. Minárik, D. Zemánek, P. Čadová, S. Homolová, K. Čurila, M. Pěnička, L. Benešová, B. Belšánová, P. Gregor, J. Veselka

. 2014 ; 60 (1) : 28-34.

Language English Country Czech Republic

Document type Journal Article

Hypertrophic cardiomyopathy is the most common genetic cardiac disease with vast genetic heterogeneity. First-degree relatives of patients with HCM are at 50% risk of inheriting the disease-causing mutation. Genetic testing is helpful in identifying the relatives harbouring the mutations. When genetic testing is not available, relatives need to be examined regularly. We tested a cohort of 99 unrelated patients with HCM for mutations in MYH7, MYBPC3, TNNI3 and TNNT2 genes. In families with identified pathogenic mutation, we performed genetic and clinical examination in relatives to study the influence of genetic testing on the management of the relatives and to study the usefulness of echocardiographic criteria for distinguishing relatives with positive and negative genotype. We identified 38 genetic variants in 47 patients (47 %). Fifteen of these variants in 21 patients (21 %) were pathogenic mutations. We performed genetic testing in 52 relatives (18 of them (35 %) yielding positive results). Genetic testing of one HCM patient allowed us to omit 2.45-5.15 future cardiologic examinations of the relatives. None of the studied echocardiographic criteria were significantly different between the relatives with positive and negative genotypes, with the exception of a combined echocardiographic score (genotype positive vs. genotype negative, 3.316 vs. -0.489, P = 0.01). As a conclusion, our study of HCM patients and their relatives confirmed the role of genetic testing in the management of the relatives and found only limited benefit of the proposed echocardiographic parameters in identifying disease-causing mutation carriers.

000      
00000naa a2200000 a 4500
001      
bmc14078166
003      
CZ-PrNML
005      
20141107080344.0
007      
ta
008      
141105s2014 xr f 000 0|eng||
009      
AR
035    __
$a (PubMed)24594054
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xr
100    1_
$a Tomašov, Pavol, $d 1982- $7 xx0243010 $u Department of Cardiology, Second Faculty of Medicine, Charles University in Prague and University Hospital Motol, Prague, Czech Republic
245    10
$a Genetic testing in the management of relatives of patients with hypertrophic cardiomyopathy / $c P. Tomašov, M. Minárik, D. Zemánek, P. Čadová, S. Homolová, K. Čurila, M. Pěnička, L. Benešová, B. Belšánová, P. Gregor, J. Veselka
520    9_
$a Hypertrophic cardiomyopathy is the most common genetic cardiac disease with vast genetic heterogeneity. First-degree relatives of patients with HCM are at 50% risk of inheriting the disease-causing mutation. Genetic testing is helpful in identifying the relatives harbouring the mutations. When genetic testing is not available, relatives need to be examined regularly. We tested a cohort of 99 unrelated patients with HCM for mutations in MYH7, MYBPC3, TNNI3 and TNNT2 genes. In families with identified pathogenic mutation, we performed genetic and clinical examination in relatives to study the influence of genetic testing on the management of the relatives and to study the usefulness of echocardiographic criteria for distinguishing relatives with positive and negative genotype. We identified 38 genetic variants in 47 patients (47 %). Fifteen of these variants in 21 patients (21 %) were pathogenic mutations. We performed genetic testing in 52 relatives (18 of them (35 %) yielding positive results). Genetic testing of one HCM patient allowed us to omit 2.45-5.15 future cardiologic examinations of the relatives. None of the studied echocardiographic criteria were significantly different between the relatives with positive and negative genotypes, with the exception of a combined echocardiographic score (genotype positive vs. genotype negative, 3.316 vs. -0.489, P = 0.01). As a conclusion, our study of HCM patients and their relatives confirmed the role of genetic testing in the management of the relatives and found only limited benefit of the proposed echocardiographic parameters in identifying disease-causing mutation carriers.
650    _2
$a mladiství $7 D000293
650    _2
$a dospělí $7 D000328
650    _2
$a srdeční myosiny $x genetika $7 D024722
650    _2
$a hypertrofická kardiomyopatie $x diagnóza $x genetika $7 D002312
650    _2
$a transportní proteiny $x genetika $7 D002352
650    _2
$a kohortové studie $7 D015331
650    _2
$a echokardiografie $7 D004452
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a genetické testování $7 D005820
650    _2
$a genetická variace $7 D014644
650    _2
$a genotyp $7 D005838
650    _2
$a heterozygot $7 D006579
650    _2
$a lidé $7 D006801
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a lidé středního věku $7 D008875
650    _2
$a mutace $7 D009154
650    _2
$a těžké řetězce myosinu $x genetika $7 D018995
650    _2
$a troponin T $x genetika $7 D020107
650    _2
$a mladý dospělý $7 D055815
655    _2
$a časopisecké články $7 D016428
700    1_
$a Minárik, Marek, $d 1970- $7 xx0071043 $u Laboratory for Molecular Genetics and Oncology, Genomac Research Institute, Prague, Czech Republic
700    1_
$a Zemánek, David, $d 1972- $7 xx0079099 $u Department of Cardiology, Second Faculty of Medicine, Charles University in Prague and University Hospital Motol, Prague, Czech Republic
700    1_
$a Čadová, Pavla $7 xx0257532 $u Department of Cardiology, Second Faculty of Medicine, Charles University in Prague and University Hospital Motol, Prague, Czech Republic
700    1_
$a Homolová, Stanislava $7 _AN033515 $u Department of Cardiology, Second Faculty of Medicine, Charles University in Prague and University Hospital Motol, Prague, Czech Republic
700    1_
$a Čurila, Karol $7 xx0073736 $u Third Department of Internal Medicine - Department of Cardiology, University Hospital Královské Vinohrady, Prague, Czech Republic
700    1_
$a Pěnička, Martin $7 xx0083039 $u Third Department of Internal Medicine - Department of Cardiology, University Hospital Královské Vinohrady, Prague, Czech Republic
700    1_
$a Mináriková, Lucie $7 xx0105258 $u Laboratory for Molecular Genetics and Oncology, Genomac Research Institute, Prague, Czech Republic
700    1_
$a Belšánová, Barbora $u Laboratory for Molecular Genetics and Oncology, Genomac Research Institute, Prague, Czech Republic. $7 xx0258802
700    1_
$a Gregor, Pavel, $d 1952- $7 jn20000400806 $u Third Department of Internal Medicine - Department of Cardiology, University Hospital Královské Vinohrady, Prague, Czech Republic
700    1_
$a Veselka, Josef, $d 1965- $7 pna2005261820 $u Department of Cardiology, Second Faculty of Medicine, Charles University in Prague and University
773    0_
$w MED00011004 $t Folia biologica $x 0015-5500 $g Roč. 60, č. 1 (2014), s. 28-34
856    41
$u https://fb.cuni.cz/file/5712/FB%2060%2001%2004-www.pdf $y plný text volně přístupný
910    __
$a ABA008 $b A 970 $c 89 $y 4 $z 0
990    __
$a 20141105 $b ABA008
991    __
$a 20141105141547 $b ABA008
999    __
$a ok $b bmc $g 1046626 $s 877154
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2014 $b 60 $c 1 $d 28-34 $i 0015-5500 $m Folia biologica (Praha) $n Folia biol. (Praha) $x MED00011004
LZP    __
$b NLK118 $a Pubmed-20141105

Find record

Citation metrics

Loading data ...

Archiving options

Loading data ...